FDA NDC Directory · JSON-LD · Markdown

Evenity

NDC 55513-998 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameromosozumab-aqqg
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA761062
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsROMOSOZUMAB (105 mg/1.17mL)
Marketing started20240701
Package count1

External sources

Source: openFDA. Public-domain (CC0).